A real-world characterization of a population with eosinophilic esophagitis: looking for severity biomarkers

被引:0
|
作者
Caldeira, Leonor esteves [1 ]
Limao, Rita [1 ]
Bras, Rita [1 ]
Pedro, Elisa [1 ]
Costa, Celia [1 ,2 ]
机构
[1] Ctr Hosp Univ Lisboa Norte EPE, Hosp Santa Maria, Dept Immunoallergol, Lisbon, Portugal
[2] Univ Clin Immunoallergol, Med Fac Lisbon, Lisbon, Portugal
关键词
Atopy; eosinophilic esophagitis; food allergy; sensitization; severity biomarkers; HISTOLOGIC REMISSION; GUIDELINES; MANAGEMENT; DIAGNOSIS; EFFICACY; CHILDREN;
D O I
10.23822/EurAnnACI.1764-1489.292
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background. Eosinophilic esophagitis (EoE) is an immune-mediated chronic esophageal disease, with frequent association with atopy. A vali- dated non/minimally invasive biomarker of disease severity has not been identified. We aimed to determine if sensitization to airborne , food allergens correlates with disease severity , to evaluate the association between clinical and laboratory characteristics with the severity of EoE. Methods. Retrospective study of EoE patients observed in a differentiated center, 2009-2021. The association between patients' diagnosis age, disease duration before diagnosis, sensitization to airborne/food allergens, serum total IgE and peripheral blood eosinophil values and severe clinical disease (presence of symptoms with a significant impact on quality of life and/or >= 1 hospital admission due to EoE complications, namely severe dysphagia, food impaction or esophageal perforation) and histological severe disease (>= 55 eos/hpf and/or microabscesses in esophageal biopsies) was evaluated. Results. 92 patients were observed, 83% male, 87% atopic. There was a mean delay in diagnosis of 4 years (range 0-31). 84% had aeroallergen sensitization and 71% food sensitization. Food impaction and dysphagia were the most frequent symptoms, and severe clinical disease was observed in 55%. Histologically, 37% had severity criteria. Patients with severe clinical disease had a significantly longer mean disease duration before diagnosis than patients without severe clinical disease (79 vs 15 months; p = 0.021). Patients who described food impaction were significantly older at time of diagnosis than those who have never had impaction (18 vs 9 years; p < 0.001). There was no significant association (p < 0.05) between sensitization, serum total IgE and peripheral blood eosinophil values and clinical or histological severity. Conclusions. An older age at diagnosis and a longer disease duration before diagnosis appear to be useful for pre- dicting EoE clinical severity. Despite having been demonstrated a high prevalence of allergic disease, the presence of sensitization to airborne and/ or food allergens do not seem to be useful for predicting clinical or histo- logical severity.
引用
收藏
页码:252 / 262
页数:11
相关论文
共 50 条
  • [41] Understanding the GOLD 2011 Strategy as applied to a real-world COPD population
    Vestbo, Jorgen
    Vogelmeier, Claus
    Small, Mark
    Higgins, Victoria
    RESPIRATORY MEDICINE, 2014, 108 (05) : 729 - 736
  • [42] Real-World Effectiveness of AntieIL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization
    Dhariwal, Jaideep
    Hearn, Andrew P.
    Kavanagh, Joanne E.
    d'Ancona, Grainne
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Roxas, Cris
    Kent, Brian D.
    Nanzer, Alexandra M.
    Jackson, David J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06) : 2315 - +
  • [43] Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study
    Mitsiki, Eirini
    Gaga, Mina
    Georgatou-Papageorgiou, Niki
    Katsaounou, Paraskevi
    Kosmas, Epameinondas
    Koulouris, Nikolaos
    Panitti, Elena
    Siafakas, Nikolaos
    Steiropoulos, Paschalis
    Toumpis, Michail
    Tzanakis, Nikolaos
    Vassilakopoulos, Theodoros
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [44] Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
    Vestbo, Jorgen
    Vogelmeier, Claus F.
    Small, Mark
    Siddall, James
    Fogel, Robert
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 853 - 861
  • [45] Patient and physician perspectives on alopecia areata: A real-world assessment of severity and burden in Japan
    Edson-Heredia, Emily
    Aranishi, Toshihiko
    Isaka, Yoshitaka
    Anderson, Peter
    Marwaha, Simran
    Piercy, James
    JOURNAL OF DERMATOLOGY, 2022, 49 (06) : 575 - 583
  • [46] Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application
    Huang, Kai
    Wu, Xian
    Li, Yixin
    Lv, Chengzhi
    Yan, Yangtian
    Wu, Zhe
    Zhang, Mi
    Huang, Weihong
    Jiang, Zixi
    Hu, Kun
    Li, Mingjia
    Su, Juan
    Zhu, Wu
    Li, Fangfang
    Chen, Mingliang
    Chen, Jing
    Li, Yongjian
    Zeng, Mei
    Zhu, Jianjian
    Cao, Duling
    Huang, Xing
    Huang, Lei
    Hu, Xing
    Chen, Zeyu
    Kang, Jian
    Yuan, Lei
    Huang, Chengji
    Guo, Rui
    Navarini, Alexander
    Kuang, Yehong
    Chen, Xiang
    Zhao, Shuang
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [47] Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients
    Reumkens, Carmen
    Endres, Adrian
    Simons, Sami O.
    Savelkoul, Paul H. M.
    Sprooten, Roy T. M.
    Franssen, Frits M. E.
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [48] Real-world effects of antidepressants for depressive disorder in primary care: population-based cohort study
    De Crescenzo, Franco
    De Giorgi, Riccardo
    Garriga, Cesar
    Liu, Qiang
    Fazel, Seena
    Efthimiou, Orestis
    Hippisley-Cox, Julia
    Cipriani, Andrea
    BRITISH JOURNAL OF PSYCHIATRY, 2024,
  • [49] Super-responder analysis and real-world one year effectiveness of benralizumab in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhariwal, Jaideep
    Nanzer, Alexandra M. A.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [50] We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database
    Rafaniello, Concetta
    Sullo, Maria Giuseppa
    Carnovale, Carla
    Pozzi, Marco
    Stelitano, Barbara
    Radice, Sonia
    Bernardini, Renato
    Rossi, Francesco
    Clementi, Emilio
    Capuano, Annalisa
    FRONTIERS IN PSYCHIATRY, 2020, 11